Concepedia

Publication | Closed Access

Serum level of CCL2 predicts outcome of patients with pancreatic cancer.

16

Citations

19

References

2020

Year

Abstract

Our results suggest that serum level of CCL2 may serve as a potential marker for predicting the outcome of patients with pancreatic cancer.

References

YearCitations

Page 1